Vera Therapeutics VERA Income Statement (2020-2026)

NASDAQ VERA
$32.38 -0.13 (-0.38%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Vera Therapeutics Quarterly Income Statement

Periods 26 quarters
Latest Jun 2026

Vera Therapeutics reported net income of -$108.99M for the quarter ended Jun 2026. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
20.97M21.28M26.76M27.00M27.66M27.80M44.26M44.32M44.43M44.45M54.70M54.83M63.32M63.56M63.77M63.82M63.93M71.27M71.78M72.06M
Operating items
Research & DevelopmentR&D
3.56M12.75M12.55M10.11M19.66M26.68M25.11M16.23M16.10M20.79M23.20M29.31M40.31M33.35M41.28M58.20M56.47M59.31M86.01M60.08M
Selling, General & AdministrativeSG&A
3.69M3.83M4.47M4.95M5.59M6.91M6.15M5.74M5.66M6.24M7.91M8.03M9.49M15.57M15.92M21.95M27.46M34.90M39.12M52.41M
Restructuring CostsRestructuring
-0.12M
Other Operating ExpensesOther Opex
0.12M
Operating ExpensesOpex
7.25M16.59M17.02M15.06M25.24M33.58M31.26M21.97M21.76M27.03M31.11M37.34M49.80M48.91M57.19M80.14M83.93M94.21M125.13M112.49M
Operating IncomeOp. Inc
-7.25M-16.59M-17.02M-15.06M-25.24M-33.58M-31.26M-21.97M-21.76M-27.03M-31.11M-37.34M-49.80M-48.91M-57.19M-80.14M-83.93M-94.21M-125.13M-112.49M
EBIT
-7.25M-16.59M-17.02M-15.06M-25.24M-33.58M-31.26M-21.97M-21.76M-27.03M-31.11M-37.34M-49.80M-48.91M-57.19M-80.14M-83.93M-94.21M-125.13M-112.49M
Non-operating items
Non Operating Interest Expenses
0.02M0.12M0.13M0.15M0.60M0.87M0.91M0.94M1.06M1.91M1.91M1.94M1.87M1.79M1.87M1.96M1.90M1.82M1.85M
Non Operating Investment Income
-0.36M-0.29M-0.26M-0.20M-0.06M-0.00M-0.03M-0.01M-0.00M-0.00M-0.01M
Interest & Investment IncomeInt & Inv Inc
0.01M0.01M0.03M0.26M0.57M0.89M1.62M2.24M2.16M1.96M4.19M5.10M4.76M6.66M6.91M6.32M5.74M5.52M6.36M5.35M
Non Operating IncomeNon Op. Inc.
-0.36M-0.26M-0.06M0.20M0.56M1.14M1.19M1.81M1.65M1.37M2.73M3.63M3.17M5.49M5.50M3.61M3.64M3.11M4.10M3.02M
Net income details
EBT
-7.25M-16.60M-17.11M-14.92M-24.82M-33.29M-30.51M-20.64M-20.54M-26.12M-28.83M-34.15M-46.98M-44.12M-52.08M-75.69M-80.16M-90.59M-120.60M-108.99M
Profit After TaxPAT
-7.25M-16.60M-17.11M-14.92M-24.82M-33.29M-30.51M-20.64M-20.54M-26.12M-28.83M-34.15M-46.98M-44.12M-52.08M-75.69M-80.16M-90.59M-120.60M-108.99M
Income from Continuing OperationsIncome (Continuing)
-7.25M-16.60M-17.11M-14.92M-24.82M-33.29M-30.51M-20.64M-20.54M-26.12M-28.83M-34.15M-46.98M-44.12M-52.08M-75.69M-80.16M-90.59M-120.60M-108.99M
Consolidated Net IncomeConsol Net Inc.
-7.25M-16.60M-17.11M-14.92M-24.82M-33.29M-30.51M-20.64M-20.54M-26.12M-28.83M-34.15M-46.98M-44.12M-52.08M-75.69M-80.16M-90.59M-120.60M-108.99M
Income towards Parent CompanyParent Net Inc
-7.61M-16.85M-17.09M-14.85M-24.68M-32.44M-30.07M-20.16M-20.10M-25.66M-28.38M-33.71M-46.63M-43.42M-51.69M-76.53M-80.29M-91.10M-121.03M-109.47M
Net Income towards Common StockholdersNet Income
-7.61M-16.85M-17.09M-14.85M-24.68M-32.44M-30.07M-20.16M-20.10M-25.66M-28.38M-33.71M-46.63M-43.42M-51.69M-76.53M-80.29M-91.10M-121.03M-109.47M
Additional items
EPS (Basic)
-0.36-1.25-0.71-0.55-0.91-1.22-0.80-0.46-0.45-0.60-0.56-0.62-0.85-0.78-0.81-1.20-1.26-1.42-1.69-1.52
EPS (Diluted)
-0.36-1.25-0.71-0.55-0.91-1.22-0.80-0.46-0.45-0.60-0.56-0.62-0.85-0.78-0.81-1.20-1.26-1.42-1.69-1.52
Shares Outstanding
21.27M13.44M24.23M27.08M27.22M26.57M37.67M44.27M44.36M42.71M50.97M54.73M54.90M55.33M63.67M63.79M63.85M64.23M71.48M71.84M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
21.27M13.44M24.23M27.08M27.22M26.57M37.67M44.27M44.36M42.71M50.97M54.73M54.90M55.33M63.67M63.79M63.85M64.23M71.48M71.84M
EBITDA
-7.19M-16.55M-17.01M-15.16M-25.40M-34.18M-31.76M-21.45M-21.75M-27.02M-31.10M-37.33M-49.78M-48.86M-57.11M-80.02M-83.80M-94.07M-124.99M-112.36M
Interest ExpensesInt Expense
0.02M0.12M0.13M0.15M0.60M0.87M0.91M0.94M1.06M1.91M1.91M1.94M1.87M1.79M1.87M1.96M1.90M1.82M1.85M

Vera Therapeutics Income Statement API

Pull Vera Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VERA&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY